MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ymgme.2023.107674

Медицинская библиотека · Molecular genetics and metabolism · 2023

Association between acute complications in PMM2-CDG patients and haemostasis anomalies: Data from a multicentric study and suggestions for acute management.

Wicker Camille, Roux Charles-Joris, Goujon Louise, de Feraudy Yvan, Hully Marie, Brassier Anais, Bérat Claire-Marine, Chemaly Nicole, Wiedemann Arnaud, Damaj Lena, Abi-Warde Marie-Thérèse, Dobbelaere Dries, Roubertie Agathe, Cano Aline, Arion Alina, Kaminska Anna, Da Costa Sabrina, Bruneel Arnaud, Vuillaumier-Barrot Sandrine, Boddaert Nathalie, Pascreau Tiffany, Borgel Delphine, Kossorotoff Manoelle, Harroche Annie, de Lonlay P

Многоцентровое исследованиеСтатьяПеревод пока не подготовлен

Аннотация

OBJECTIVES

Patients with PMM2-CDG develop acute events (stroke-like episodes (SLEs), thromboses, haemorrhages, seizures, migraines) associated with both clotting factors (factor XI) and coagulation inhibitors (antithrombin, protein C and protein S) deficiencies. The aim of the study was to correlate acute events to haemostasis and propose practical guidelines.

METHODS

In this multicentric retrospective study, we evaluated clinical, radiological, haemostasis and electroencephalography data for PMM2-CDG patients hospitalized for acute events. Cerebral events were classified as thrombosis, haemorrhage, SLE, or "stroke mimic" (SM: normal brain imaging or evoking a migraine).

RESULTS

Thirteen patients had a total of 31 acute episodes: 27 cerebral events with 7 SLEs, 4 venous thromboses, 4 haemorrhages (3 associated with thrombosis), 15 SMs at a mean age of 7.7 years; 4 non-cerebral thromboses, one of which included bleeding. A trigger was frequently involved (infection, head trauma). Although sometimes normal at baseline state, factor XI, antithrombin and protein C levels decreased during these episodes. No correlation between haemostasis anomalies and type of acute event was found.

DISCUSSION: Acute events in PMM2-CDG are not negligible and are associated with haemostasis anomalies. An emergency protocol is proposed for their prevention and treatment (https://www.filiere-g2m.fr/urgences). For cerebral events, brain Magnetic Resonance Imaging with perfusion weight imaging and diffusion sequences, electroencephalogram and haemostasis protein levels guide the treatment: anticoagulation, antithrombin or fresh frozen plasma supplementation, antiepileptic therapy. Preventing bleeding and thrombosis is required in cases of surgery, prolonged immobilization, hormone replacement therapy.

CONCLUSION

Acute events in PMM2-CDG are associated with abnormal haemostasis, requiring practical guidance.

Для цитирования: Wicker Camille, Roux Charles-Joris, Goujon Louise, de Feraudy Yvan, Hully Marie, Brassier Anais, Bérat Claire-Marine, Chemaly Nicole, Wiedemann Arnaud, Damaj Lena, Abi-Warde Marie-Thérèse, Dobbelaere Dries, Roubertie Agathe, Cano Aline, Arion Alina, Kaminska Anna, Da Costa Sabrina, Bruneel Arnaud, Vuillaumier-Barrot Sandrine, Boddaert Nathalie, Pascreau Tiffany, Borgel Delphine, Kossorotoff Manoelle, Harroche Annie, de Lonlay P. Association between acute complications in PMM2-CDG patients and haemostasis anomalies: Data from a multicentric study and suggestions for acute management.. Molecular genetics and metabolism. 2023. DOI: 10.1016/j.ymgme.2023.107674.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.